Apotex Inc - Company & Market Research Reports

Home /
Companies /
Apotex Inc

Apotex Inc. was founded in 1974, and is the largest Canadian-owned pharmaceutical company. The company employs over 10,000 people in research, development, manufacturing and distribution facilities worldwide. Apotex produces more than 300 generic pharmaceuticals in approximately 4,000 dosages and formats which, in Canada, are used to fill over 89 million prescriptions a year - the largest amount of any pharmaceutical company in this country.

REFINE BY

KEYWORD

CATEGORIES

Cardiovascular Drugs 52
Central Nervous System Drugs 44
Generic Drugs 38
Oncology Drugs 32
Biosimilars and Biosuperiors 26
Immune Disorders Drugs 25
Infectious Diseases Drugs 25
Analgesics 24
Mental Disorders Drugs 22
Endocrine and Metabolic Disorders Drugs 22
Gastrointestinal Drugs 21
Musculoskeletal Disorders Drugs 21
Respiratory Drugs 19
Animal Pharmaceuticals 18
Over the Counter (OTC) Drugs 17
Sexual and Reproductive Health Drugs 16
Pharmaceuticals 15
Anxiety Drugs 15
Hematological Drugs 14
Lung Cancer Drugs 13
Immunosuppressive Drugs 13
Breast Cancer Drugs 12
Optical Disorders Drugs 11
Ovarian Cancer Drugs 10
Infusions and Injectables 10
Transdermal and Transmucosal Drug Delivery 9
Urological Disorders Drugs 9
Schizophrenia Drugs 8
Addiction Disorders Drugs 7
Pharmaceutical Intermediates 7
Diabetes Drugs 7
Biopharmaceuticals 7
Pancreatic Cancer Drugs 7
Antibiotics 7
Liver and Kidney Disorders Drugs 6
Drug Discovery 5
Liver Cancer Drugs 5
Prostate Cancer Drugs 5
Leukemia Drugs 5
Colon Cancer Drugs 5
Thyroid Cancer Drugs 5
Asthma Drugs 5
Anesthetic Drugs 4
Drug Delivery 4
Skin Cancer Drugs 4
Kidney Cancer Drugs 4
Vitamins and Dietary Supplements 4
Allergy Drugs 4
Alzheimer's Disease Drugs 4
Psoriasis Drugs 4
Pharmaceutical Manufacturing 4
Bladder Cancer Drugs 3
Bronchitis Drugs 3
Company Reports 2
Lymphoma Drugs 2
Cervical Cancer Drugs 2
Clinical Trials 2
Vaccines 2
Dermatological Drugs 2
Acne Drugs 2
Drugs by Therapeutic Area 1
Brain Cancer Drugs 1
Cough and Cold Drugs 1
Inhalers and Nebulisers 1
Anti-Obesity Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



278 reviews

445 Results (Page 6 of 23)
- Relevance
  Sort by

Metformin Hydrochloride & Glipizide Tablets Market - Global Forecast to 2030

 Report
August 2025
182 Pages
Global

From

€3127EUR$3,545USD£2,707GBP

€3474EUR$3,939USD£3,007GBP

Montelukast Sodium - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
110 Pages
Global

From

€4189EUR$4,750USD£3,626GBP

Gonorrhea Therapeutics Market 2025-2029

 Report
July 2025
220 Pages
Global

From

€2205EUR$2,500USD£1,909GBP

Rivastigmine Hydrogen Tartrate Capsules Market - Global Forecast 2025-2030

 Report
August 2025
185 Pages
Global

From

€3127EUR$3,545USD£2,707GBP

€3474EUR$3,939USD£3,007GBP

Rivastigmine Tartrate Drug Market - Global Forecast 2025-2030

 Report
August 2025
197 Pages
Global

From

€3127EUR$3,545USD£2,707GBP

€3474EUR$3,939USD£3,007GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

LAMEA Gabapentin Market Size, Share & Industry Trends Analysis Report by Application, Dosage Form, Distribution Channel, Country and Growth Forecast, 2022-2028

 Report
March 2023
84 Pages
Middle East, Africa

From

€1323EUR$1,500USD£1,145GBP

Asia Pacific Gabapentin Market Size, Share & Industry Trends Analysis Report by Application, Dosage Form, Distribution Channel, Country and Growth Forecast, 2022-2028

 Report
March 2023
84 Pages
Asia Pacific

From

€1323EUR$1,500USD£1,145GBP

Europe Gabapentin Market Size, Share & Industry Trends Analysis Report by Application, Dosage Form, Distribution Channel, Country and Growth Forecast, 2022-2028

 Report
March 2023
85 Pages
Europe

From

€1323EUR$1,500USD£1,145GBP

North America Gabapentin Market Size, Share & Industry Trends Analysis Report by Application, Dosage Form, Distribution Channel, Country and Growth Forecast, 2022-2028

 Report
March 2023
74 Pages
North America

From

€1323EUR$1,500USD£1,145GBP

Miconazole Nitrate Vaginal Soft Capsules Market - Global Forecast to 2030

 Report
August 2025
198 Pages
Global

From

€3127EUR$3,545USD£2,707GBP

€3474EUR$3,939USD£3,007GBP

Non-Opioid Pain Patch Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3960EUR$4,490USD£3,428GBP

Specialty Generics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030

 Report
December 2023
255 Pages
Global

From

€1102EUR$1,250USD£954GBP

€2205EUR$2,500USD£1,909GBP

Topical Ocular Immunosuppressants Market - Global Forecast 2025-2030

 Report
August 2025
192 Pages
Global

From

€3127EUR$3,545USD£2,707GBP

€3474EUR$3,939USD£3,007GBP

Overactive Bladder Treatment (OAB) Market by Drug type ( Anticholinergic (Solifenacin, Oxybutynin, Tolterodine, Darifenacin), Mirabegron), Botox, Neuromodulation, Disease Type (Idopathic OAB and Neurogenic OAB) and Region - Global Forecasts to 2027

 Report
July 2022
203 Pages
Global

From

€6306EUR$7,150USD£5,459GBP

Immunosuppressants Market Report 2025

 Report
April 2025
175 Pages
Global

From

€3960EUR$4,490USD£3,428GBP

Pregabalin - Global Strategic Business Report

 Report
September 2025
372 Pages
Global

From

€5159EUR$5,850USD£4,466GBP

Ophthalmic Drug Delivery System Market - Global Forecast 2025-2030

 Report
August 2025
181 Pages
Global

From

€3127EUR$3,545USD£2,707GBP

€3474EUR$3,939USD£3,007GBP

Schizophrenia Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
February 2024
133 Pages
Global

From

€3500EUR$4,251USD£3,136GBP

Filgrastim & Biosimilars Market - Global Forecast 2025-2030

 Report
August 2025
190 Pages
Global

From

€3127EUR$3,545USD£2,707GBP

€3474EUR$3,939USD£3,007GBP

Ceritinib Capsules Market - Global Forecast 2025-2030

 Report
August 2025
185 Pages
Global

From

€3127EUR$3,545USD£2,707GBP

€3474EUR$3,939USD£3,007GBP

445 Results (Page 6 of 23)
- 1
- 4
- 5
- 6
- 7
- 8

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.